Lv1
40 积分 2022-03-16 加入
Association between Complete Proteinuria Remission and Kidney Function in the Phase 3 PROTECT Trial of Sparsentan in IgA Nephropathy
20小时前
求助中
Time-Varying Proteinuria and Progression of IgA Nephropathy: A Cohort Study
2个月前
已完结
Efficacy and safety of a targeted-release formulation of budesonide in patients with primary IgA nephropathy (NefIgArd): 2-year results from a randomised phase 3 trial
5个月前
已完结
皖公网安备34019202002308
